IBDEI11E ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17594,1,3,0)
 ;;=3^Stress on family d/t rtrn of family member from deployment
 ;;^UTILITY(U,$J,358.3,17594,1,4,0)
 ;;=4^Z63.71
 ;;^UTILITY(U,$J,358.3,17594,2)
 ;;=^5063171
 ;;^UTILITY(U,$J,358.3,17595,0)
 ;;=Z03.89^^73^850^1
 ;;^UTILITY(U,$J,358.3,17595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17595,1,3,0)
 ;;=3^Observation for Suspected Diseases & Condition Ruled Out
 ;;^UTILITY(U,$J,358.3,17595,1,4,0)
 ;;=4^Z03.89
 ;;^UTILITY(U,$J,358.3,17595,2)
 ;;=^5062656
 ;;^UTILITY(U,$J,358.3,17596,0)
 ;;=E11.9^^73^851^11
 ;;^UTILITY(U,$J,358.3,17596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17596,1,3,0)
 ;;=3^Type 2 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,17596,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,17596,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,17597,0)
 ;;=E11.65^^73^851^9
 ;;^UTILITY(U,$J,358.3,17597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17597,1,3,0)
 ;;=3^Type 2 DM w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,17597,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,17597,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,17598,0)
 ;;=E10.9^^73^851^6
 ;;^UTILITY(U,$J,358.3,17598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17598,1,3,0)
 ;;=3^Type 1 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,17598,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,17598,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,17599,0)
 ;;=E10.65^^73^851^4
 ;;^UTILITY(U,$J,358.3,17599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17599,1,3,0)
 ;;=3^Type 1 DM w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,17599,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,17599,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,17600,0)
 ;;=E11.42^^73^851^7
 ;;^UTILITY(U,$J,358.3,17600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17600,1,3,0)
 ;;=3^Type 2 DM w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,17600,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,17600,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,17601,0)
 ;;=E10.42^^73^851^2
 ;;^UTILITY(U,$J,358.3,17601,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17601,1,3,0)
 ;;=3^Type 1 DM w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,17601,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,17601,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,17602,0)
 ;;=E13.42^^73^851^1
 ;;^UTILITY(U,$J,358.3,17602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17602,1,3,0)
 ;;=3^Secondary Type DM w/ Diabetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,17602,1,4,0)
 ;;=4^E13.42
 ;;^UTILITY(U,$J,358.3,17602,2)
 ;;=^5002686
 ;;^UTILITY(U,$J,358.3,17603,0)
 ;;=E10.621^^73^851^3
 ;;^UTILITY(U,$J,358.3,17603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17603,1,3,0)
 ;;=3^Type 1 DM w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,17603,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,17603,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,17604,0)
 ;;=E10.649^^73^851^5
 ;;^UTILITY(U,$J,358.3,17604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17604,1,3,0)
 ;;=3^Type 1 DM w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,17604,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,17604,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,17605,0)
 ;;=E11.621^^73^851^8
 ;;^UTILITY(U,$J,358.3,17605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17605,1,3,0)
 ;;=3^Type 2 DM w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,17605,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,17605,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,17606,0)
 ;;=E11.649^^73^851^10
 ;;^UTILITY(U,$J,358.3,17606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17606,1,3,0)
 ;;=3^Type 2 DM w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,17606,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,17606,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,17607,0)
 ;;=99201^^74^852^1
 ;;^UTILITY(U,$J,358.3,17607,1,0)
 ;;=^358.31IA^2^2
